Millipore Sigma Vibrant Logo

569397 Staurosporine, Streptomyces sp.

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
62996-74-1C₂₈H₂₆N₄O₃

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
569397-100UG
Retrieving availability...
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 100 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      569397-250UG
      Retrieving availability...
      Limited Availability
Limited Availability
      In Stock 
      Discontinued
      Limited Quantities Available
      Availability to be confirmed
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 250 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity is a multiple of
          Maximum Quantity is
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits protein kinase A (IC50 = 7 nM), CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase C (IC50 = 700 pM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint. A 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569396) in DMSO is also available.
          Catalogue Number569397
          Brand Family Calbiochem®
          SynonymsMLCK Inhibitor I, PKA Inhibitor II
          References
          ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
          Product Information
          CAS number62996-74-1
          ATP CompetitiveY
          FormWhite to pale yellow solid
          Hill FormulaC₂₈H₂₆N₄O₃
          Chemical formulaC₂₈H₂₆N₄O₃
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetPKA
          Primary Target IC<sub>50</sub>7 nM, 20 nM, 1.3 nM, 700 pM, and 8.5 nM against protein kinase A , CaM kinase, myosin light chain kinase, protein kinase C, and protein kinase G, respectively
          Purity≥99% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Catalogue Number GTIN
          569397-100UG 07790788057855
          569397-250UG 04055977190496

          Documentation

          Staurosporine, Streptomyces sp. SDS

          Title

          Safety Data Sheet (SDS) 

          Staurosporine, Streptomyces sp. Certificates of Analysis

          TitleLot Number
          569397

          References

          Reference overview
          Couldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.

          Brochure

          Title
          Caspases and other Apoptosis Related Tools Brochure
          Protein Kinase Assay and Detection Kits Brochure
          Tools and Tips for Analyzing Apoptosis

          Citations

          Title
        • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
        • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
        • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
        • Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision17-July-2014 JSW
          SynonymsMLCK Inhibitor I, PKA Inhibitor II
          DescriptionA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.
          FormWhite to pale yellow solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number62996-74-1
          Chemical formulaC₂₈H₂₆N₄O₃
          Structure formulaStructure formula
          Purity≥99% by HPLC
          SolubilityDMSO (5 mg/ml). Further dilute with aqueous buffers just prior to use.
          Storage Protect from light
          +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Toxicity Standard Handling
          ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
          Citation
        • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
        • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
        • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
        • Related Products & Applications

          Categories

          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase C (PKC) Inhibitors
          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors